Prevention of recurrent menstrual psychosis by an oral contraceptive

Case report OA: closed CC0 ⤵ 4 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

A patient with recurrent menstrual psychosis experienced resolution of psychotic symptoms upon regular administration of oral contraceptives.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A 21-year-old unmarried female, with a history of periodic psychotic behavior, was admitted to the hospital after exhibiting overt psychotic symptoms. Several months of hospital observtion and a review of her earlier psychotic episodes suggested that the patient's psychotic behavior was associated with the onset of menses. The symptoms disappeared after oral contraceptives were administered on a regular basis. The patient experienced her 1st psychotic episode 1 year after menache. Several episodes during the intervening years required hospitalization. One of these episodes occurred during a period of prolonged menstrual flow. The patient's menstrual cycles were frequently irregular. During the present hospitalization the patient exhibited psychotic symptoms at the onset of 3 of her 4 menstrual cycles. She became agitated and delusional and exhibited dissociated thought patterns and autonomic symptoms. Despite the use of high doses of antipsychotic drugs, the symptoms persisted until the menstrual flow stopped 7 days later. After the 3rd episode the patient did not menstruate for 2 months. 69 days after the onset of her last menstrual flow the patient was given Provera to induce menstruation. 5 days later the menstrual flow began and Ortho-Novum 1/50 was administered. During the next 6 months she took the contraceptive regularly and remained free of any overt symptoms. The mechanism by which oral contraceptives prevent menstrual psychosis is unknown. Perhaps the estrogen decreases monoamine oxidase activity which in turn alters the level of norepinephine at the synapses.

My notes (saved in your browser only)

MeSH descriptors

Contraceptives, Oral Contraceptives, Oral, Hormonal Menstruation Disturbances Neurocognitive Disorders Adult Antipsychotic Agents Antipsychotic Agents Contraceptives, Oral Contraceptives, Oral, Hormonal Female Humans Menstruation Disturbances Neurocognitive Disorders Recurrence

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

References (5)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:58:02.984372+00:00
unpaywall
last seen: 2026-10-22T06:24:31.118836+00:00
License: CC0 · commercial use OK